US Stock MarketDetailed Quotes

GRI Bio (GRI)

Watchlist
  • 1.450
  • -0.050-3.33%
Close Jul 24 16:00 ET
  • 1.450
  • 0.0000.00%
Post 20:01 ET
2.57MMarket Cap-0.21P/E (TTM)

GRI Bio (GRI) Cash Flow

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: USD
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
2022/Q3
2022/Q2
2022/Q1
Operating Cash Flow
-112.27%-3.69M
-48.62%-2.97M
-1.98%-2.31M
-47.87%-3.17M
+21.20%-1.74M
+64.05%-2.00M
-73.00%-2.27M
-71266.67%-2.14M
-4.11%-2.20M
-558.77%-5.56M
-948.80%-1.31M
-100.14%-3.00K
+7.60%-2.12M
---844.00K
---125.00K
--2.17M
---2.29M
Net cash flow from continuing operations
-112.27%-3.69M
-48.62%-2.97M
-1.98%-2.31M
-47.87%-3.17M
+21.20%-1.74M
+64.05%-2.00M
-73.00%-2.27M
-71266.67%-2.14M
-4.11%-2.20M
-558.77%-5.56M
-948.80%-1.31M
-100.14%-3.00K
+7.60%-2.12M
---844.00K
---125.00K
--2.17M
---2.29M
Net Income from Continuing Operations
+34.41%-2.00M
-36.50%-2.66M
-58.29%-3.36M
-28.53%-2.89M
-61.42%-3.05M
+2.79%-1.95M
+0.70%-2.12M
+65.38%-2.25M
+21.24%-1.89M
+11.68%-2.00M
-508.83%-2.14M
-418.94%-6.50M
+9.07%-2.40M
---2.27M
---351.00K
--2.04M
---2.64M
Gain/Loss from Continuing Operations
----
----
----
----
----
+100.00%0.00
+100.00%0.00
---1.00K
-103.17%-2.00K
---200.00K
---45.00K
--0.00
--63.00K
----
----
----
----
Depreciation & Depletion & Amortization
+0.00%1.00K
+0.00%1.00K
+0.00%1.00K
+0.00%1.00K
+0.00%1.00K
+0.00%1.00K
+0.00%1.00K
-50.00%1.00K
--1.00K
+0.00%1.00K
+0.00%1.00K
+111.11%2.00K
-100.00%0.00
--1.00K
--1.00K
---18.00K
--19.00K
Other Non-Cash Items
+18.18%13.00K
----
----
+108.51%12.00K
-21.43%11.00K
----
----
---141.00K
--14.00K
-69.19%53.00K
---26.00K
----
----
--172.00K
----
----
----
Change in Working Capital
-260.67%-1.73M
-288.12%-392.00K
+392.27%567.00K
-253.99%-328.00K
+394.54%1.08M
+97.04%-101.00K
-136.53%-194.00K
-95.19%213.00K
-377.27%-366.00K
-482.81%-3.41M
+216.07%531.00K
+1248.78%4.42M
+2.33%132.00K
--890.00K
--168.00K
--328.00K
--129.00K
-Change in Prepaid Assets
-46.43%105.00K
-55.56%-14.00K
+375.00%132.00K
+67.53%-63.00K
-65.25%196.00K
-103.11%-9.00K
+44.19%-48.00K
+71.80%-194.00K
+1009.68%564.00K
+1132.14%289.00K
-8700.00%-86.00K
-1363.83%-688.00K
-258.97%-62.00K
---28.00K
--1.00K
---47.00K
--39.00K
-Change in Payables and Accrued Expense
-304.26%-1.82M
-357.50%-366.00K
+429.41%448.00K
-195.11%-253.00K
+197.49%893.00K
+97.83%-80.00K
-121.59%-136.00K
-94.83%266.00K
-572.16%-916.00K
-497.62%-3.68M
+251.96%630.00K
+1191.96%5.14M
+115.56%194.00K
--926.00K
--179.00K
--398.00K
--90.00K
-Change in Other Current Liabilities
-18.18%-13.00K
+0.00%-12.00K
-30.00%-13.00K
-108.51%-12.00K
+21.43%-11.00K
+14.29%-12.00K
+23.08%-10.00K
--141.00K
---14.00K
-75.00%-14.00K
-8.33%-13.00K
----
----
---8.00K
---12.00K
----
----
Net cash flow from investing
----
----
----
----
----
--0.00
--0.00
----
----
+100.00%0.00
--0.00
+99.31%-8.00K
-100.00%0.00
---3.00K
--0.00
---1.15M
--1.15M
Net Cash Flow from Continuing Investing Activities
----
----
----
----
----
--0.00
--0.00
----
----
+100.00%0.00
--0.00
+99.31%-8.00K
-100.00%0.00
---3.00K
--0.00
---1.15M
--1.15M
Net PPE Purchase and Sale
----
----
----
----
----
--0.00
--0.00
----
----
+100.00%0.00
--0.00
----
----
---3.00K
--0.00
----
----
Net Investment Purchase and Sale
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
----
----
----
--1.15M
Financing Cash Flow
+59227.27%6.50M
+213.37%7.15M
+88.50%1.25M
+13.72%5.01M
-100.25%-11.00K
-41.21%2.28M
--661.00K
-36.35%4.40M
--4.49M
+415.96%3.88M
-100.00%0.00
+11825.86%6.92M
+100.00%0.00
--752.00K
--220.00K
--58.00K
---23.00K
Net Cash Flow from Continuing Financing Activities
+59227.27%6.50M
+213.37%7.15M
+88.50%1.25M
+13.72%5.01M
-100.25%-11.00K
-41.21%2.28M
--661.00K
-36.35%4.40M
--4.49M
+415.96%3.88M
-100.00%0.00
+11825.86%6.92M
+100.00%0.00
--752.00K
--220.00K
--58.00K
---23.00K
Net Issuance Payments Of Debt
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
--0.00
-100.00%0.00
-100.00%0.00
+5334.78%1.25M
+100.00%0.00
--1.00M
--250.00K
--23.00K
---23.00K
Net Common Stock Issuance
+681900.00%6.82M
+395.05%8.00M
+57.80%1.62M
+19.78%5.94M
-100.02%-1.00K
--1.62M
--1.03M
--4.96M
--5.50M
+100.00%0.00
--0.00
----
----
---124.00K
--0.00
----
----
Proceeds from Stock Option Exercised
----
----
----
----
----
--761.00K
--1.00K
----
----
--0.00
--0.00
----
----
--0.00
--0.00
----
----
Net Other Financing Charges
-3040.00%-314.00K
-787.50%-852.00K
-1.91%-373.00K
-67.68%-934.00K
+99.01%-10.00K
-102.47%-96.00K
---366.00K
---557.00K
---1.01M
+3229.03%3.88M
+100.00%0.00
----
----
---124.00K
---30.00K
----
----
Ending Cash Balance
+236.73%11.05M
+63.66%8.23M
-14.56%4.06M
-19.38%5.12M
-19.80%3.28M
+178.10%5.03M
+36.07%4.75M
+32.38%6.35M
+145.71%4.09M
+19988.89%1.81M
+3253.85%3.49M
+53222.22%4.80M
-34.53%1.67M
--9.00K
--104.00K
--9.00K
--2.54M
Net Change in Cash
+261.36%2.82M
+1380.14%4.17M
+33.60%-1.07M
-18.61%1.84M
-176.52%-1.75M
+116.79%282.00K
-22.58%-1.61M
-67.25%2.26M
+207.89%2.28M
-1668.42%-1.68M
-1480.00%-1.31M
+540.63%6.91M
-82.57%-2.12M
---95.00K
--95.00K
--1.08M
---1.16M
Beginning Cash Balance
+63.66%8.23M
-14.56%4.06M
-19.38%5.12M
-19.80%3.28M
+178.10%5.03M
+36.07%4.75M
+32.38%6.35M
+145.71%4.09M
-52.18%1.81M
+3253.85%3.49M
+53222.22%4.80M
-34.53%1.67M
+2.13%3.78M
--104.00K
--9.00K
--2.54M
--3.70M
Free Cash Flow
-112.27%-3.69M
-48.77%-2.97M
-1.98%-2.31M
-47.87%-3.17M
+21.20%-1.74M
+64.05%-2.00M
-73.00%-2.27M
-19363.64%-2.14M
-4.11%-2.20M
-556.43%-5.56M
-948.80%-1.31M
-100.51%-11.00K
+7.60%-2.12M
---847.00K
---125.00K
--2.17M
---2.29M
Deadline
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Accounting Standard
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
2026/Q12025/Q42025/Q32025/Q22025/Q12024/Q42024/Q32024/Q22024/Q12023/Q42023/Q32023/Q22023/Q12022/Q42022/Q32022/Q22022/Q1
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Latest: Citing a senior Iranian official, foreign media reported on the 20th that intermediaries in Iran-U.S. negotiations have presented Te Show More